Embecta

Embecta Equity

The The Equity of Embecta (EMBC) as of Oct 19, 2026 is -651.20 M USD. In the previous year, The Equity was -738.30 M USD — a change of -11.80% (higher).

Equity

-651.20 MUSD

YoY

-11.80%

Last updated:

In 2025, Embecta's equity was -651.20 M USD, a -11.80% increase from the -738.30 M USD equity in the previous year.

The Embecta Equity history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Equity
Date
Equity
Jan 1, 2019
577.00 M USD
Jan 1, 2020
572.00 M USD
Jan 1, 2021
594.00 M USD
Jan 1, 2022
-891.40 M USD
Jan 1, 2023
-821.70 M USD
Jan 1, 2024
-738.30 M USD
Jan 1, 2025
-651.20 M USD
The Embecta Equity history
YEAREquityYoY
-651.20 MUSD-11.80%
-738.30 MUSD-10.15%
-821.70 MUSD-7.82%
-891.40 MUSD-250.07%
594.00 MUSD+3.85%
572.00 MUSD-0.87%
577.00 MUSD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Embecta Stock analysis

What does Embecta do? Embecta Corp, headquartered in Parsippany, New Jersey, operates in the Health Care sector, manufacturing and distributing medical devices for diabetes treatment. The company employs 1,850 full-time staff and offers a portfolio including pen needles, syringes, safety injection devices, and a digital application for diabetes management. Its products, such as sterile single-use pen needles and safety pen needles with automatic shields, are designed to enhance user safety and convenience. Embecta distributes through retail, hospital, pharmacy, and institutional channels. Embecta is one of the most popular companies on Eulerpool.

Equity Details

Analyzing Embecta's Equity

Embecta's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding Embecta's equity is essential for assessing its financial health, stability, and value to shareholders.

Year-to-Year Comparison

Evaluating Embecta's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.

Impact on Investments

Embecta's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.

Interpreting Equity Fluctuations

Fluctuations in Embecta’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.

Frequently Asked Questions about Embecta stock

The Equity of Embecta is -651.20 M USD in 2025.

The Equity of Embecta changed from -738.30 M USD to -651.20 M USD, representing a -11.80% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of The Equity Embecta since 2006 – with annual values, charts, and detailed analysis.

The Equity's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track The Equity's Embecta historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Embecta

All Key Metrics — Embecta